These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11304866)

  • 1. Voluntary screening program for HIV in pregnancy. Cost effectiveness.
    Rivera-Alsina ME; Rivera CC; Rollene N; Kirby RS; Ayres A; McNamara M
    J Reprod Med; 2001 Mar; 46(3):243-8. PubMed ID: 11304866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
    Kumar M; Birch S; Maturana A; Gafni A
    Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
    Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME
    Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness estimates for antenatal HIV testing in the Netherlands.
    Rozenbaum MH; Verweel G; Folkerts DK; Dronkers F; van den Hoek JA; Hartwig NG; de Groot R; Postma MJ
    Int J STD AIDS; 2008 Oct; 19(10):668-75. PubMed ID: 18824618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine prenatal screening for HIV in a low-prevalence setting.
    Patrick DM; Money DM; Forbes J; Dobson SR; Rekart ML; Cook DA; Middleton PJ; Burdge DR
    CMAJ; 1998 Oct; 159(8):942-7. PubMed ID: 9834719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
    Mrus JM; Tsevat J
    Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of voluntary prenatal and routine newborn HIV screening.
    AIDS Read; 2001 Feb; 11(2):81. PubMed ID: 11279876
    [No Abstract]   [Full Text] [Related]  

  • 9. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
    Plunkett BA; Grobman WA
    Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.
    Mauskopf JA; Paul JE; Wichman DS; White AD; Tilson HH
    JAMA; 1996 Jul; 276(2):132-8. PubMed ID: 8656505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
    Immergluck LC; Cull WL; Schwartz A; Elstein AS
    Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Would universal antenatal screening for HIV infection be cost-effective in a setting of very low prevalence? Modelling the data for Australia.
    Graves N; Walker DG; McDonald AM; Kaldor JM; Ziegler JB
    J Infect Dis; 2004 Jul; 190(1):166-74. PubMed ID: 15195257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-effectiveness analysis of HIV screening in pregnant women in hospitals in the Paris region].
    Le Galès C; Moatti JP
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(1):36-42. PubMed ID: 2107247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmaco-economic evaluation of mandatory HIV-screening in pregnancy; a cost-efficacy analysis in Amsterdam].
    Postma MJ; van den Hoek JA; Beck EJ; Heeg B; Jager JC; Coutinho RA
    Ned Tijdschr Geneeskd; 2000 Apr; 144(16):749-54. PubMed ID: 10812443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of HIV screening in acute care settings.
    Owens DK; Nease RF; Harris RA
    Arch Intern Med; 1996 Feb; 156(4):394-404. PubMed ID: 8607724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis.
    Doyle NM; Levison JE; Gardner MO
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1280-5. PubMed ID: 16157152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department.
    Dowdy DW; Rodriguez RM; Hare CB; Kaplan B
    Acad Emerg Med; 2011 Jul; 18(7):745-53. PubMed ID: 21762236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the cost of preventing AIDS transmission from mothers to children: an effect analysis].
    Guo JL; Wang YM; Liang SY; Wang Z; Hu XY; Zhang L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Mar; 28(3):258-60. PubMed ID: 17649659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid HIV testing and prevention of perinatal HIV transmission in high-risk maternity hospitals in St. Petersburg, Russia.
    Kissin DM; Akatova N; Rakhmanova AG; Vinogradova EN; Voronin EE; Jamieson DJ; Glynn MK; Yakovlev A; Robinson J; Miller WC; Hillis S
    Am J Obstet Gynecol; 2008 Feb; 198(2):183.e1-7. PubMed ID: 18226620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assessment of mother-to-child HIV transmission prevention in 16 pilot antenatal clinics in Jamaica.
    Harvey KM; Figueroa JP; Tomlinson J; Gebre Y; Forbes S; Toyloy T; Thompson T; Thompson K
    West Indian Med J; 2004 Oct; 53(5):293-6. PubMed ID: 15675493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.